Nanocarriers targeting senescent cells
Ageing and multiple chronic diseases in humans associate with an aberrant accumulation of senescent cells in a diversity of tissues, which contributes to organ dysfunction and drives their pathological manifestations. It emerges that elimination of senescent cells ameliorates and even reverts the pr...
Main Author: | Daniel Muñoz-Espín |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2019-01-01
|
Series: | Translational Medicine of Aging |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468501118300075 |
Similar Items
-
Targeting senescent cells in translational medicine
by: Marta Paez‐Ribes, et al.
Published: (2019-12-01) -
Tumor Targeted Nanocarriers for Immunotherapy
by: Alejandro Baeza
Published: (2020-03-01) -
A versatile drug delivery system targeting senescent cells
by: Daniel Muñoz‐Espín, et al.
Published: (2018-09-01) -
Biomimetic Nanocarriers for Cancer Target Therapy
by: Clara Guido, et al.
Published: (2020-09-01) -
Targeted Delivery of Protein Drugs by Nanocarriers
by: Antonella Battisti, et al.
Published: (2010-03-01)